Crohn's Disease and Colitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years old or older
- You have been diagnosed with moderate to severe Crohn's disease, based on a standard disease activity score
- Your Crohn's disease affects specific parts of your bowel (the ileum and/or colon), and this has been confirmed by a camera examination (colonoscopy) showing ulcers meeting certain levels of severity
- A stool test or blood test shows signs of significant inflammation in your body
- You have never previously been treated with any biologic medication (a type of advanced treatment made from living cells)
- You have either not responded to, cannot tolerate, or are medically unable to take standard treatments such as steroids, immune-suppressing drugs, or antibiotics
- You have freely agreed to take part and signed a consent form
Who may not be able to join:
- You have had a previous allergic reaction to humanised protein-based medicines (confirm with trial site)
- You have used steroid medications within the 8 weeks before your screening appointment
- You currently have a narrowing of the intestine or back passage causing symptoms, an untreated abscess inside the abdomen or around the back passage, have had abdominal surgery within the last 6 months, or are expected to need bowel surgery during the study — though people who have had an abscess properly drained at least 4–8 weeks before the study starts may still be eligible (confirm with trial site)
- You currently have active tuberculosis (TB) — though people who have been fully treated and confirmed cured may still be eligible (confirm with trial site)
- You have latent (inactive) TB — though people who have completed or are near completing the proper treatment for latent TB may still be eligible (confirm with trial site)
- You have tested positive for the hepatitis B surface antigen, or have certain other hepatitis B blood test results showing a high level of the virus in your blood (confirm with trial site)
- You have tested positive for hepatitis C antibodies
- You have a history of HIV infection or have tested positive for HIV
- You have a serious heart condition classified as Class III or IV (meaning significant limitations on physical activity or symptoms at rest)
- You currently have an active infection of any kind
- You have or have had cancer in the last 5 years (certain skin cancers and cervical cancer may be exceptions — confirm with trial site), or have had pre-cancerous changes in the bowel within the last 5 years
- You are currently pregnant or breastfeeding
- You are not using, or do not plan to use, a reliable form of contraception for at least 6 months after your last dose of the study drug (accepted methods include hormonal contraceptives, condoms, diaphragm, coil, or abstinence)
- The trial doctors have decided for any other reason that joining the trial would not be appropriate for you
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Byong Duk Ye, MD, PhD, Asan Medical Center
Phone: 82-2-3010-3181
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Deep remission rate of Arm 3 compared with Arm 2
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.